Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - REVENUE
Revenue EXEL - Exelixis, Inc.
1.83 B
LAST VALUE
12.94%
2 YEAR CAGR
16.47%
5 YEAR CAGR
50.19%
10 YEAR CAGR